Nuformix (LON:NFX) Stock Price Down 32.4% – What’s Next?

Nuformix plc (LON:NFX) dropped 32.4% during trading on Wednesday . The stock traded as low as GBX 0.10 ($0.00) and last traded at GBX 0.10 ($0.00). Approximately 343,525,563 shares changed hands during trading, an increase of 375% from the average daily volume of 72,272,914 shares. The stock had previously closed at GBX 0.15 ($0.00).

Nuformix Stock Down 29.7 %

The firm has a 50-day moving average of GBX 0.06 and a 200 day moving average of GBX 0.10. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.12 and a quick ratio of 3.35. The stock has a market capitalization of £835,696.20, a price-to-earnings ratio of -1.63 and a beta of 1.22.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.